The comparison of our results with those of Jacobi et al. in SCA3 and SCA6 [18], and our own SCA7 SARA score, indicated that our patients with ADCA who receive IGF-1 treatment showed a stabilization of disease progression. This evidence concerns the gene ATXN3 and autosomal dominant cerebellar ataxia.